Related Experiment Video
Updated: Aug 11, 2026

Generation of Organotypic Raft Cultures from Primary Human Keratinocytes
Published on: February 22, 2012
Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes
L M Alvarez-Salas1, A E Cullinan, A Siwkowski
1Laboratory of Biology, Division of Basic Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4255, USA.
Abstract:
HPV-16 E6 and E7 genes are required to efficiently immortalize a broad spectrum of cell types including cervical keratinocytes. Therefore, the E6/E7 genes can be considered relevant targets for anti-cancer therapy. We produced several engineered hairpin (HP) ribozymes to specifically disrupt HPV-16 E6/E7 mRNA. After extensive biochemical characterization, one anti-E6 HP ribozyme (R434) was selected for in vivo testing because of its superior catalytic capabilities. When expressed in cis, R434 efficiently inhibited E6 in vitro translation. Cis-expression of the HP ribozyme with HPV-16 E6/E7 genes in normal human keratinocytes reduced the growth rate and prevented immortalization. RNA analysis by reverse transcription-PCR showed that E6/E7 transcripts were cleaved in post-transfected cells and virtually were eliminated after long term expression. Of interest, an inactive version of the HP also was able to significantly affect the immortalizing ability of E6/E7, probably through passive hybridization. The combination of passive and cleaving antisense RNA therefore is established as an effective inhibitor of HPV-16 E6/E7 immortalization.
Insights
Engineered ribozymes targeting Human Papillomavirus type 16 (HPV-16) E6 and E7 genes effectively inhibit cervical keratinocyte immortalization. This dual-action approach, combining cleavage and passive hybridization, shows promise for anti-cancer therapy.
Area of Science:
- Molecular Biology
- Virology
- Biochemistry
Background:
- Human Papillomavirus type 16 (HPV-16) E6 and E7 oncoproteins are crucial for cervical keratinocyte immortalization.
- These oncoproteins represent significant therapeutic targets for cervical cancer treatment.
Purpose of the Study:
- To develop and evaluate engineered hairpin (HP) ribozymes for disrupting HPV-16 E6/E7 mRNA.
- To assess the efficacy of a specific anti-E6 HP ribozyme (R434) in inhibiting HPV-16-mediated immortalization in vitro and in vivo.
Main Methods:
- Production and biochemical characterization of engineered HP ribozymes targeting HPV-16 E6/E7 mRNA.
- In vitro translation inhibition assays using the selected R434 ribozyme.
- Cis-expression of R434 in normal human keratinocytes containing HPV-16 E6/E7 genes.
- Reverse transcription-PCR (RT-PCR) analysis to quantify E6/E7 transcript cleavage and elimination.
Main Results:
- The R434 ribozyme demonstrated efficient inhibition of E6 in vitro translation.
- Cis-expression of R434 in keratinocytes reduced cell growth rate and prevented immortalization.
- RT-PCR confirmed cleavage and substantial elimination of E6/E7 transcripts in transfected cells.
- An inactive HP ribozyme also showed inhibitory effects, suggesting a role for passive hybridization.
Conclusions:
- Engineered HP ribozymes are effective inhibitors of HPV-16 E6/E7 mRNA.
- The combination of catalytic cleavage and passive hybridization by antisense RNA provides a potent strategy against HPV-16-induced immortalization.
- This approach holds potential for developing novel anti-cancer therapies targeting HPV-driven cancers.
Related Concept Videos
Negative Regulator Molecules
Experimental RNAi
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly

